Citigroup, Inc (NYSE: C) Maintains “Buy” Rating on DaVita Inc (NYSE: DVA) - American Banking News Print
American Banking NewsThe analysts wrote, “ESRD final rule was better than the 9/09 Proposed rule (namely the under-funded oral rx was delayed), but not perfect, as CMS finalized

... read more